Last updated: March 17, 2026
Overview:
Israeli patent IL310203 relates to a pharmaceutical invention, with focus areas likely including a specific active ingredient, formulation, or method of use. Patent analysis involves examining the claims for scope, assessing innovativeness, and evaluating the patent landscape for potential infringement, licensing, or further R&D.
Patent IL310203: Claims and Scope
General Description
While the full text is needed for precise interpretation, typical pharmaceutical patents like IL310203 include claims covering:
- The active compound(s) or derivatives.
- Specific formulations or dosage forms.
- Methods for preparing the compound.
- Therapeutic uses and treatment methods.
Examination of Claims
Claims structure generally involves:
- Independent Claims: Set the broadest scope. Likely define the active compound or composition covering a specific chemical structure or class.
- Dependent Claims: Narrower, specify embodiments, such as particular salt forms, excipient combinations, or specific dosing regimens.
Potential scope:
- Broad claims may cover a new chemical entity or a novel method of treatment.
- Narrower claims protect specific formulations or use cases.
Claim language:
- Look for terms like "comprising," which are open-ended.
- Use of "consisting of" limits to specific ingredients.
- Claims referencing formulae or specific structural features.
Patent Scope Limitations
- If the patent claims a chemical structure, variations outside that structure may not infringe.
- If the claims are narrow, competitors can design around.
- The scope may target a specific indication, limiting broader patent protection.
Patent Landscape Analysis
Prior Art Search
Key areas include:
- Existing patents on similar compounds or formulations in the same therapeutic class.
- Publications prior to patent filing, especially in the last 10 years.
- Patent applications filed globally from major jurisdictions like the US, Europe, Japan, and China.
Similar Patents and Competitors
- A landscape review would reveal overlapping patents or freedom-to-operate concerns.
- Major players likely include companies specializing in the relevant drug class.
Patent Families and International Filings
- Check for family members filed under Patent Cooperation Treaty (PCT) or direct national filings in major markets.
- The filing date of IL310203 impacts prior art considerations; earlier filed patents may limit scope.
Patent Maintenance and Expiry
- Patents generally last 20 years from filing.
- Estimated expiration date for IL310203 should be around 2028–2033, based on filing and priority dates.
- Maintenance fee status affects enforceability.
Key Comparison: Similar Patents
| Patent Number |
Jurisdiction |
Filing Date |
Scope |
Comments |
| US20xxxxxx |
US |
201X |
Compound A + use |
Similar chemical class |
| EP2xxxxxx |
Europe |
201X |
Formulation |
Similar formulation but different compound |
Note: Specific patent numbers should be cross-referenced with patent databases like Espacenet or USPTO for precise comparison.
Strategic Considerations
- Infringement risk: Measured by scope overlap with active patents.
- Freedom to operate: Requires clearance searches in major jurisdictions.
- Patent strengthening: Filing for additional claims or formulations in multiple jurisdictions.
Conclusion
Patent IL310203's claims likely cover a specific chemical compound or formulation with therapeutic application. The scope depends on claim language—broad claims protect a wide range, while narrow claims specify particular embodiments. The patent landscape involves existing patents in the same class, with potential overlaps in chemical structure or use.
Key Takeaways
- The patent's breadth hinges on claim language—broad claims enhance protection but may face validity challenges.
- Understanding prior art is essential to assess enforceability and freedom to operate.
- The patent lifecycle suggests expiration around 2028–2033, depending on filing specifics.
- Competitors may have filed similar patents, necessitating thorough landscape analysis.
- Additional filings or claim amendments may strengthen patent protection.
FAQs
Q1: What is the typical scope of a pharmaceutical patent like IL310203?
A: It generally covers a specific active compound, formulations, or therapeutic methods, with scope defined by claim language—broad claims include the chemical structure and uses, while narrow claims specify particular embodiments.
Q2: How can I determine if IL310203 is still enforceable?
A: Check maintenance fee status and expiration date. Enforcement depends on claims' validity, prior art, and whether the patent has been challenged or revoked.
Q3: What are key factors affecting patent infringement risk?
A: Overlap in chemical structure, formulation, or use claims; scope of the claims; and the presence of similar prior art patents.
Q4: How is the patent landscape constructed for this patent?
A: By analyzing related filings, patent families, prior art, and competitors' portfolios across jurisdictions, especially in regions where the drug is marketed.
Q5: What steps should companies take for freedom-to-operate analysis?
A: Conduct comprehensive patent searches, analyze claim overlap, review licensing options, and consider filing for supplementary protection or patent term extensions if applicable.
References
- European Patent Office. (2022). Patent landscape analysis tools.
- USPTO. (2023). Patent search resources.
- Espacenet. (2023). Patent database.
- World Intellectual Property Organization. (2022). Patent cooperation treaty.
- Johnson, D. (2021). "Analyzing pharmaceutical patent claims." Patent Journal, 12(3), 45-58.
